Zhang, Yifan <br/><br/>
A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice.  [electronic resource] 

 -  Kidney international  09 2018 
 - 524-535 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1016/j.kint.2018.05.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--drug therapy<br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Blood Glucose--metabolism<br/>Capillaries--drug effects<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Fibrosis<br/>Gene Knockdown Techniques<br/>Glucose Transporter Type 2--genetics<br/>Humans<br/>Kidney Tubules, Proximal--blood supply<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Reperfusion Injury--complications<br/>Sodium-Glucose Transporter 2--metabolism<br/>Sodium-Glucose Transporter 2 Inhibitors--pharmacology<br/>Sorbitol--analogs & derivatives<br/>Sunitinib--pharmacology<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--metabolism